Prev Close | 25.34 |
Day Low/High | 24.35 / 25.69 |
52 Wk Low/High | 10.01 / 28.45 |
Prev Close | 25.34 |
Day Low/High | 24.35 / 25.69 |
52 Wk Low/High | 10.01 / 28.45 |
Exchange | NYSE |
Shares Outstanding | 45.66B |
Market Cap | 1.16B |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
It's behavioral finance at its finest, and makes for a fascinating debate.
And why maintaining a small position in defense stocks is important.
Stock futures pointed lower following the Fed's decision to raise interest rates and ahead of potential new tariff announcements from President Trump. Here's what you need to know.
John Flannery sees progress being made on GE's initiatives, but that is what I expected him to say.
Can all of Time's numerous brands survive if its $2.8 billion deal to be acquired by Meredith comes to fruition.
Meredith Corporation pulls the trigger on a huge media deal that will surely get the publishing industry talking.
Wall Street futures drift into the red as investors pulled cash from global equity markets amid concerns that tech sector shares could be due for a correction
A better-than-expected quarter from Cisco Systems Inc. drives gains in the tech sector and pushes the Nasdaq to a closing high.
Time is reportedly in talks with Meredith again
Valeant Pharmaceuticals (VRX) tumbled Monday as Congressional Democrats asked to subpoena the company for documents related to drug price increases.
U.S. stocks opened sharply higher Tuesday as investors come back to work after the Labor Day Holiday weekend.
Two old-school publishers continue to thrive in the digital age.
These two names may not be sexy, but they offer solid dividend growth.
Portfolio Manager David Peltier features a hot, low-dollar stock that could keep moving higher.
The list expands to 28 with a new emphasis on financial services.
Small-caps that raise their dividends year after year signify company health and confident management.